Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
The microfluidics market was valued at USD 24.18 Billion in 2025. It is poised to grow at a CAGR of 7.80% during the forecast period of 2026-2035, and reach USD 51.24 Billion by 2035. The growth is supported by the rising adoption of point-of-care diagnostic platforms and increasing investments in pharmaceutical and life sciences research, alongside continuous innovation in lab-on-a-chip and organ-on-chip technologies.
According to PatSnap, microfluidic diagnostics in April 2026 are being shaped by three converging forces, including the push toward fully integrated sample-to-result platforms, the digitization of amplification assays through digital PCR, and the proliferation of smartphone-coupled point-of-care devices. These trends reinforce accelerating venture investment, regulatory progress, and durable growth across the global microfluidics market.
According to Analytical Chemistry, an early-2026 review highlighted how AI and machine learning-driven biofluidics platforms are reshaping clinical diagnostics, sepsis detection, and healthcare intelligence applications. Integration of CRISPR detection, chemiluminescence immunoassay, and biochemical analysis on single chips is accelerating sub-one-hour diagnostic turnaround, reinforcing premium positioning and durable expansion across the global microfluidics market across decentralized healthcare settings.
Compound Annual Growth Rate
7.8%
Value in USD Billion
2026-2035
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Microfluidics involves the precise handling of nanolitre to microlitre volumes of fluids through engineered microchannels, enabling integrated diagnostic, genomic, and analytical workflows on a single chip. Key application areas include in vitro diagnostics, lab-on-a-chip platforms, organ-on-chip systems, drug discovery, and life sciences research. The market is poised to grow at a CAGR of 7.80%, driven by the rising demand for point-of-care diagnostics, increasing adoption of lab-on-chip technologies, and growing investments in pharmaceutical and biotechnology research. Advancements in organ-on-chip platforms, genomics applications, and automation technologies are further accelerating growth. The increasing integration of microfluidic systems in drug discovery and clinical diagnostics continues to enhance efficiency, accuracy, and scalability across healthcare and research industries globally.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Advancements in Microfluidic Cell Isolation Technologies to Enhance the Market Value
The increasing adoption of advanced microfluidic technologies for rare cell isolation, enabling improved precision in cancer research, drug discovery, and regenerative medicine applications, is a key factor driving the growth in the market. The rising demand for high-throughput single-cell analysis and improved cell viability during encapsulation further supports market expansion. For example, in June 2024, Bio-Rad Laboratories, Inc. launched Celselect Slides 2.0 to enhance circulating tumor cell capture and increase sample processing capacity by 2.5 times, improving downstream genomic analysis workflows. This development highlights accelerating innovation and strengthens the adoption of microfluidic cell enrichment platforms worldwide.
Some of the notable trends in the market are rising adoption of lab-on-chip platforms, automation in genomic workflows, and integration of digital microfluidics for diagnostics.
Growing Automated Digital Microfluidics Platforms to Transform Genomics Workflows and Enhance Market Landscape
The increasing integration of automated digital microfluidics platforms is significantly transforming next-generation sequencing workflows by improving accuracy, speed, and operational efficiency. This trend began gaining traction with the launch of advanced systems designed to streamline NGS sample preparation. For example, in September 2023, INTEGRA Biosciences introduced the MIRO CANVAS platform, a digital microfluidics system that fully automates NGS library preparation and reduces manual intervention. Such innovations minimize errors, reduce reagent consumption, and enhance throughput in genomics research. The rising adoption of automated microfluidic solutions is expected to enhance scalability and drive sustained growth in the global microfluidics market.
Market Breakup by Product
Market Breakup by Material
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Polydimethylsiloxane (PDMS) is Expected to Lead the Market Segmentation by Material
The material segment in the microfluidics market includes polymer, silicon, glass, polydimethylsiloxane (PDMS), and others. Among these, polydimethylsiloxane (PDMS) accounted for around 34% market share in the historical period and is expected to maintain a leading position during the forecast period. PDMS is widely preferred due to its optical transparency, flexibility, gas permeability, and cost-effectiveness, making it highly suitable for lab-on-chip and organ-on-chip applications. Although polymers, silicon, and glass continue to support niche and high-performance applications, PDMS is anticipated to dominate the material segment owing to its strong adoption in academic research and rapid prototyping of microfluidic devices across life sciences and diagnostic workflows.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Among all the regions, North America is expected to dominate the global microfluidics market, supported by advanced healthcare infrastructure, strong R&D funding, the presence of leading manufacturers, and rapid clinical adoption of point-of-care diagnostics and next-generation sequencing platforms. Asia Pacific is anticipated to grow at the fastest pace, supported by expanding biotechnology and pharmaceutical sectors across China, Japan, and India, government investment in domestic medical device manufacturing, and rising clinical research activity. Europe maintains steady growth through robust academic research networks, government grants for organ-on-chip programmes, and growing adoption of microfluidic platforms in personalised medicine and drug discovery applications.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Illumina, Inc. develops advanced digital microfluidics technology based on electrowetting to precisely manipulate nanoliter droplets for sequencing library preparation, quantification, and normalization. Its integrated systems reduce manual lab steps and enable automated biochemical workflows for genomics research. The company actively contributes to the microfluidics market through next-generation sequencing platforms, supporting high-throughput, scalable, and efficient genetic analysis solutions globally.
F. Hoffmann-La Roche AG offers the LumiraDx point-of-care diagnostic system powered by actively controlled microfluidics for rapid testing using small blood or swab samples. Its portable platform enables fast, reliable detection across cardiovascular, infectious, and metabolic conditions, strengthening decentralized diagnostics. The company plays a key role in the microfluidics market by advancing accessible, near-patient testing technologies.
Revvity, Inc. provides microfluidic capillary electrophoresis systems such as LabChip® platforms for protein and nucleic acid analysis in genomics and biopharmaceutical research. It also supports custom microfluidic chip fabrication for specialized workflows. The company contributes to the microfluidics market by enabling fast, high-resolution bioanalysis and streamlined laboratory automation for research applications.
Danaher Corporation advances the microfluidics market through Cytiva’s development of microfluidic mixers for lipid nanoparticle encapsulation used in RNA therapeutics. Its technologies support device fabrication, nanoparticle engineering, and bioprocess innovation for next-generation drug delivery systems. The company strengthens its market position by enabling scalable microfluidic solutions across biotechnology and therapeutic manufacturing applications.
Other key players in the market are Bio-Rad Laboratories, Inc., Qiagen N.V., Biosurfit SA, Sphere Bio, PerkinElmer, Inc., Fluigent SAS.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment
|
| Breakup by Product |
|
| Breakup by Material |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.